() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Category Archives: Recommended Reads

Delta 9 Update on Business to Business Activities

DELTA 9 INC. (TSX:DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to provide investors with an update on its business to business (“B2B”) activities including sales of its proprietary “Grow Pod” systems, sales of genetics, and licensing and consulting services. These value-added B2B offerings provide Delta 9 with a diversified revenue stream.
Read more

1933 Industries Reports First Quarter Financial Results for Fiscal Year 2020

1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis and growth-orientated consumer packaged goods company, is pleased to announce its first quarter 2020 (“Q1”) financial results for the period ended October 31, 2019. All amounts expressed are in Canadian dollars.
Read more

Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries") a Latin American licenced producer of medicinal cannabis and cannabis-derived products, has signed a definitive joint venture agreement (the “Agreement”) with the International Research Center on Cannabis and Mental Health (“IRCCMH” or the “Center”) for the development of medical education programs for physicians and patients in Latin America and product formulation.
Read more
Get $50 in free trades.